The U.S. Supreme Court left in place a $65 million antitrust judgment against Martin Shkreli, the “Pharma Bro” who served almost seven years in prison for defrauding investors. The justices without comment turned away Shkreli’s bid to overturn the award …
Source: Claims Journal